These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31534348)
21. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway. Shi SL; Zhang ZH Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529 [TBL] [Abstract][Full Text] [Related]
22. LncRNA SNHG12 Decreases Non-Small Cell Lung Cancer Cell Sensitivity to Cisplatin by Repressing miR-525-5p and Promoting XIAP. Tan D; Wang S; Zhang P; Peng C; Wu T Ann Clin Lab Sci; 2023 Jan; 53(1):64-75. PubMed ID: 36889771 [TBL] [Abstract][Full Text] [Related]
23. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis. Wang P; Chen D; Ma H; Li Y Onco Targets Ther; 2017; 10():5137-5149. PubMed ID: 29123412 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p. Zhao J; Zeng XB; Zhang HY; Xiang JW; Liu YS Open Med (Wars); 2020; 15(1):921-931. PubMed ID: 33336050 [TBL] [Abstract][Full Text] [Related]
25. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9. Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114 [TBL] [Abstract][Full Text] [Related]
26. Silence of FOXD2-AS1 inhibited the proliferation and invasion of esophagus cells by regulating miR-145-5p/CDK6 axis. Shi W; Gao Z; Song J; Wang W Histol Histopathol; 2020 Sep; 35(9):1013-1021. PubMed ID: 32524576 [TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis. Wu C; Lin W; Fu F Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677 [TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells. Wang H; Guo M; Ding D; Yang F; Chen Z Onco Targets Ther; 2020; 13():3641-3652. PubMed ID: 32431515 [TBL] [Abstract][Full Text] [Related]
29. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p. Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864 [TBL] [Abstract][Full Text] [Related]
30. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway. Shi J; Yang C; An J; Hao D; Liu C; Liu J; Sun J; Jiang J J Exp Clin Cancer Res; 2021 Apr; 40(1):148. PubMed ID: 33931086 [TBL] [Abstract][Full Text] [Related]
31. LncRNA FOXD2-AS1 accelerates the papillary thyroid cancer progression through regulating the miR-485-5p/KLK7 axis. Zhang Y; Hu J; Zhou W; Gao H J Cell Biochem; 2019 May; 120(5):7952-7961. PubMed ID: 30456805 [TBL] [Abstract][Full Text] [Related]
32. LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma. Sui C; Dong Z; Yang C; Zhang M; Dai B; Geng L; Lu J; Yang J; Xu M J Cell Mol Med; 2019 Sep; 23(9):6024-6033. PubMed ID: 31210410 [TBL] [Abstract][Full Text] [Related]
33. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis. Wang L; Shang X; Feng Q Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109 [TBL] [Abstract][Full Text] [Related]
34. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis. Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683 [TBL] [Abstract][Full Text] [Related]
35. Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating Wang X; Wang H; Jiang H; Qiao L; Guo C Cancer Biother Radiopharm; 2023 Jun; 38(5):293-304. PubMed ID: 34339285 [No Abstract] [Full Text] [Related]
36. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis. Shen F; Chang H; Gao G; Zhang B; Li X; Jin B J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141 [TBL] [Abstract][Full Text] [Related]
37. DICER activates autophagy and promotes cisplatin resistance in non-small cell lung cancer by binding with let-7i-5p. Li C; Chen L; Song W; Peng B; Zhu J; Fang L Acta Histochem; 2021 Oct; 123(7):151788. PubMed ID: 34543777 [TBL] [Abstract][Full Text] [Related]
38. IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6 Axis. Dong B; Zhang F; Zhang W; Gao Y Crit Rev Eukaryot Gene Expr; 2023; 33(2):27-40. PubMed ID: 36734855 [TBL] [Abstract][Full Text] [Related]
39. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis. Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592 [TBL] [Abstract][Full Text] [Related]